The Prevention Standards Partnership – An overview

The European Drug Prevention Quality Standards (EDPQS) and supporting materials were developed by the EU Prevention Standards Partnership, a multi-disciplinary and multi-sectoral collaboration of academic institutions, organisations in charge of delivering local prevention and health promotion services, as well as governmental institutions from across Europe.

In Phase I, the Partnership comprised a total of 12 partners. Led by the Centre for Public Health of Liverpool John Moores University, UK, the Partnership included six Co-beneficiaries from five EU countries as well as five Associate Partners, including the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

For Phase II, the Partnership was extended to a total of 15 partners. In addition to the project lead, it comprised eight Co-beneficiaries from seven EU countries. As in the first phase, there were a number of Associate Partners, including for the first time the United Nations Office on Drugs and Crime (UNODC). Nearly all of the partners from Phase I were able to continue work on promoting the Prevention Standards as part of Phase II.

See the Phase I Partnership See the Phase II Partnership

How did partners contribute to the project?

  • The project lead (Centre for Public Health at Liverpool John Moores University, UK) had overall responsibility for the project. It was in charge of managing the Partnership and taking care of all administrative matters, such as reporting to funders. The project lead also took part in all research and dissemination activities on a par with Co-beneficiaries, and summarised findings across the Partnership.
  • Project activities were planned and implemented by the Co-beneficiaries in collaboration with the project lead. To coordinate and plan activities, the whole Partnership met at least once a year in person, with frequent email communication in-between. You can read about some of these meetings in our blog (e.g. Athens meeting, Vienna meeting, Milan meeting). Each Co-beneficiary signed up to do a specific task as part of the project, and some Co-beneficiaries also took the lead on certain activities.
  • Associate Partners signed up for different reasons. For example, in Phase I, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) supported the project by facilitating collaboration of the Partnership, providing input at all stages of the development process, and publishing the final version of Standards in its Manual series. In Phase II, some Associate Partners took part to allow case studies (i.e. they formed the ‘subject’ of the project research into how the Standards could be applied and evidenced), whilst others had an interest in following the development of the project with a view to utilising the project outputs.
  • Project advisors are not formal members of the Prevention Standards Partnership but support the project in an advisory role to ensure the practical relevance and scientific rigour of its activities. In Phase II, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) took on this responsibility.

All details of how particular institutions contributed to the project can be found on the Phase II Partnership page in the sub-sections entitled “Role in the Phase II project”.